Improving lives of people with Tourette Syndrome
Neurotherapeutics
Neupulse
Development of a new electro-stimulus wrist-worn device providing a safe and effective non-drug treatment to reduce tics and the urge to tic.
The Challenge
Translating groundbreaking scientific discovery to an everyday device that improves lives of people.
The neuroscience team at University of Nottingham had developed a therapy which dramatically reduces the frequency of tics and the urge to tic, and needed a team to develop the technology into a device for clinical trials.

The Solution
The Neupulse device, worn discreetly on the wrist, allows people with Tourette’s to control their tics at the touch of a button.

The Execution
We supported the University of Nottingham team in development of an initial prototype for use in a clinical study. The device, which provides gentle stimulation through the median nerve on the wrist, was proved to be significantly effective in reducing tics and the urge to tic. Subsequently, we supported spinout business Neurotherapeutics in development of the commercially available version of the device, Neupulse. As well as ensuring effective delivery of the median nerve stimulation, the Neupulse device takes into consideration comfort, discretion, convenient and usability.
The Neupulse device is available at www.neupulse.co

The Impact
Game-changing therapy.
Previously, there were no effective therapies for Tourette’s. The Neupulse device provides an effective non-drug treatment for tic disorder that has the potential to transform millions of lives.
“This wearable and self-managing treatment could change the lives of people living with Tourette’s.”
Emma McNally
CEO
Tourettes Action
Speak to our experts about your unique challenge
Whether you’re identifying your next innovation priority, or looking to accelerate development of an existing concept, our team will have advice to help you move forward.
Related projects
We’ve brought over 150 products to life, pioneering progress in pharma and life-saving medtech.
